Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $7.13B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $1.13B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CORT | CORCEPT THERAPEUTICS INC | $7.54B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $4.77B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NAGE | NIAGEN BIOSCIENCE INC | $587.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SPRY | ARS PHARMACEUTICALS INC | $1.39B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GYRE | GYRE THERAPEUTICS INC | $874.34M | N/A | 0.00% | $20.0200 | N/A | N/A | 0 | ||
| ARGX | ARGENX SE | $38.88B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.95B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.71B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $1.89B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $10.88B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| SRPT | SAREPTA THERAPEUTICS INC | $6.09B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $7.39B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RIGL | RIGEL PHARMACEUTICALS INC | $334.39M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $18.72B | 1.32% | 43.80% | $0.2200 | $0.43 | 28% | 0 | 2025-05-16 | 2025-06-10 |
| NVO | NOVO NORDISK A S | $292.90B | 2.46% | 45.50% | $1.0992 | $1.61 | 52% | 10 | ||
| ADMA | ADMA BIOLOGICS INC | $5.53B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $12.01B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MDXG | MIMEDX GROUP INC | $933.48M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MNKD | MANNKIND CORP | $1.50B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCYT | VERACYTE INC | $2.32B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.96B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GNFT | GENFIT SA | $203.98M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.12B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $7.85B | 0.64% | 32.00% | $0.0800 | $0.32 | 12% | 1 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $2.43B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GMAB | GENMAB A | $13.85B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| UTHR | UNITED THERAPEUTICS CORP | $13.25B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| REGN | REGENERON PHARMACEUTICALS INC | $63.70B | 0.15% | 2.10% | $0.8800 | $0.88 | 1% | 0 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.